A prognostic model to personalize monitoring regimes for patients with incidental asymptomatic meningiomas

Abstract

The model shows that there is little benefit to rigorous monitoring in low-risk and older patients with comorbidities. Risk-stratified follow-up has the potential to reduce patient anxiety and associated health care costs.